官方服务：
资源简介：
Bayesian Design of Clinical Trials Using Joint Models for Longitudinal and Time-to-event Data
应用场景：
创建时间：
2020-09-10
相关数据集
Statistical operating characteristics of current early phase dose finding designs with toxicity and efficacy in oncology
Traditional phase I dose finding cancer clinical trial designs aim to determine the maximum tolerated dose (MTD) of the investigational cytotoxic agent based on a single toxicity outcome, assuming a m
DataCite Commons2026-04-20 更新100
Randomized non-inferiority trial involving 45-year-old women attending breast cancer screening
Breast cancer screening is effective in reducing mortality from the disease. However, the sensitivity of mammography is not optimal, which limits the effectiveness of screening, particularly in younge
Zenodo2025-03-17 更新30
Sample size calculations for superiority trials.
Efficacy in the reference arm from 60–80%, delta 10–30%, alpha error 0.05, power 80–95%.
Figshare2015-12-02 更新30
Treatment Selection at Interim Analysis Based on a Correlated Early Endpoint in Adaptive Two-Stage Trials with a Primary Endpoint Based on Count Data
Adaptive two-stage design with treatment selection, also called seamless Phase II/III design, has been recognized to save sample size and time to enhance the development of effective treatments. These
Taylor & Francis Group2025-07-29 更新40
Comparison of power and standard error for the new trial under different analysis methods and different sample size allocation strategies given the total sample size.
Comparison of power and standard error for the new trial under different analysis methods and different sample size allocation strategies given the total sample size.
Figshare2023-12-21 更新30
